All In Biotech

Drug Trial Radar · NCT00091949

Insulin Resistance Intervention After Stroke Trial

Insulin Resistance Intervention After Stroke (IRIS) Trial

Last checked: Nov 20, 2026Latest source record: Apr 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 3,876 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,876

Actual

Start

Feb 2005

Primary completion

Nov 2015

Study completion Nov 2015

Sponsor

Lead sponsor
Yale UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS); Takeda Pharmaceuticals North America, Inc.
First posted
Sep 22, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.

Conditions

  • Stroke
  • Myocardial Infarction
  • Diabetes

Interventions

  • pioglitazoneDrug

    a thiazolidinedione drug

  • placeboDrug

    an inactive substance

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Recurrent Fatal or Non-fatal Stroke, or Fatal or Non-fatal Myocardial InfarctionTime frame: Up to 5 years

Locations

183 sites in 8 countries. Site status is shown where the registry gives one.

  • University of Alabama

    Birmingham, Alabama

  • University of South Alabama

    Mobile, Alabama

  • University of Arizona

    Tucson, Arizona

  • Shanti Clinical Trials (NINDS-CRC site)

    Colton, California

  • UCSF-Fresno

    Fresno, California

  • Scripps Clinic

    La Jolla, California

  • University of Southern California

    Los Angeles, California

  • University of California

    Los Angeles, California

  • Stanford University

    Palo Alto, California

  • University of California-Davis

    Sacramento, California

  • University of California

    San Diego, California

  • University of California

    San Francisco, California

  • Denver Health and Hospital Authority

    Denver, Colorado

  • Hartford

    Hartford, Connecticut

  • Yale University

    New Haven, Connecticut

  • National Rehabilitation Hospital

    Washington D.C., District of Columbia

  • University of Florida

    Gainesville, Florida

  • University of Florida

    Jacksonville, Florida

  • MIMA Century Research Associates

    Melbourne, Florida

  • Pines Neurological Associates (NINDS-CRC site)

    Pembroke Pines, Florida

  • Floria Neurovascular Institute

    Tampa, Florida

  • Cook County (Stroger) Hospital

    Chicago, Illinois

  • Rush University

    Chicago, Illinois

  • University of Illinois

    Chicago, Illinois

  • Ingalls Memorial Hospital (NINDS-CRC site)

    Harvey, Illinois

  • Loyola University Medical Center

    Maywood, Illinois

  • OSF St. Francis Medical Center

    Peoria, Illinois

  • Tri-City Neruology (NINDS-CRC site)

    Saint Charles, Illinois

  • Indiana Medical Research

    Elkhart, Indiana

  • Associates In Neurology (NINDS-CRC site)

    Valparaiso, Indiana

  • Iowa Health Des Moines Clinical Trials Office

    Des Moines, Iowa

  • Ruan Neuroscience Center/Mercy Medical Center

    Des Moines, Iowa

  • University of Iowa

    Iowa City, Iowa

  • Northeast Iowa Medical Education Foundation (NINDS-CRC site)

    Waterloo, Iowa

  • Via Christi Regional Medical Center

    Wichita, Kansas

  • University of Kentucky Research Foundation

    Lexington, Kentucky

  • Louisiana State University Health Sciences Center

    Shreveport, Louisiana

  • Penobscot Bay Neurology

    Rockport, Maine

  • Sinai Hospital of Baltimore

    Baltimore, Maryland

  • Johns Hopkins

    Baltimore, Maryland

Showing 40 of 183 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.